Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
20 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
(Updates with market close) TSMC strikes cautious note for 2027 after sixth straight record quarterly profit US producer prices rise more than expected in September Chip index falls for seventh straight day By Noel Randewich and Sruthi Shankar Oct 15 (Reuters) — The S&P 500 ended higher on Thursday, springing back from
(Updates with afternoon trading) TSMC strikes cautious note for 2027 after sixth straight record quarterly profit US producer prices rise more than expected in September S&P 500 +0.02%, Nasdaq -0.43%, Dow +0.88% By Noel Randewich and Sruthi Shankar Oct 15 (Reuters) — The S&P 500 was near flat on Thursday, recovering fr
Pfizer shares reached $29.88 Thursday, clearing the previous 52-week peak of $29.21, as drugmakers rose broadly. The FDA approved a Tukysa regimen on Oct. 7.
Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: The Morning News Call newsletter: (.) The S&P 500 and the Nasdaq tumbled on Wednesday as banks slid after quarterly results and hot inflation data boosted bets of interest rate hikes, pressuring beneficiaries of the AI buildout sensitiv
Eli Lilly shares increased to 1215.00 USD, the highest since August 2026. Over the past 4 weeks, Eli Lilly gained 6.9%, and in the last 12 months, it increased 46.93%.
Bank of America analysts raised Soitec to buy from neutral, saying photonics should significantly expand the French semiconductor-materials maker's gross margin over the coming years. They see gross margin rising to 29% in fiscal 2027, 39% in fiscal 2028 and 44% in fiscal 2029.
Citi said Novo Nordisk's third-quarter sales could come in 1% above consensus, helped by a strong Wegovy pill launch in the U.K. The bank cut its target price to 296 kroner from 310 kroner and kept a neutral rating.
Dow Jones, S&P 500 and Nasdaq futures fell early Thursday as crude oil prices and Treasury yields rose. The article also flagged Samsung, Micron, Taiwan Semiconductor and Sandisk ahead of their updates.
Dow Jones futures were little changed overnight while 10-year Treasury yields edged higher after touching a 24-year high intraday. The article also flagged Samsung, Micron, Taiwan Semiconductor and Sandisk ahead of chip-related results and sales updates.
Dow Jones futures fell 0.1%, while S&P 500 and Nasdaq-100 futures lost a fraction. The 10-year Treasury yield edged up to nearly 5.3% after a strong auction, while crude oil prices rose 1%.
Dow Jones futures were little changed after hours, while S&P 500 and Nasdaq futures also held near flat. The article also noted Samsung preliminary Q3 results, upcoming Taiwan Semiconductor sales and softer oil prices and Treasury yields.
Dow Jones futures were little changed after hours, while S&P 500 and Nasdaq futures edged higher. The article also flagged Samsung, Micron, Taiwan Semiconductor and Sandisk ahead of upcoming chip-sector results and sales reports.
Dow Jones, S&P 500 and Nasdaq futures were little changed after hours after the stock market pared losses and Treasury yields eased from intraday highs. The article also flagged upcoming Samsung preliminary results and Taiwan Semiconductor sales data.
Dow Jones futures were little changed after hours, while S&P 500 and Nasdaq futures also held near flat levels. The article also noted Samsung’s upcoming preliminary results and Taiwan Semiconductor’s sales report, alongside Wednesday’s stock market pullback and easing Treasury yields.
U.S. stocks slipped by midday Wednesday as a sharp selloff in industrials weighed on the Dow Jones and small caps, while healthcare provided a rare pocket of strength. The S&P 500 fell 0.4% to 7,788, while the Dow Jones Industrial Average dropped 0.9%, or 465 points, to 51,056. The Dow was weighed down by Caterpillar I
Eli Lilly's experimental combination drug EloraTZP led to an average body weight loss of 23.3% over 48 weeks in a mid-stage trial, compared to 14.8% for its blockbuster Zepbound alone. The company plans to start late-stage trials for EloraTZP in the fourth quarter of 2026.
The S&P 500 clawed back most of its morning decline at midday Thursday after sources told Reuters that U.S. and Iranian negotiators meeting in New York are discussing a phased deal that would have Tehran reopen the Strait of Hormuz in exchange for Washington lifting its economic blockade of Iran. The headlines took som
Eli Lilly shares were down 3.17% at $1,194.57 Wednesday, retreating after hitting all-time highs last week. The move came alongside separate positive real-world Zepbound data.
U.S. stocks drifted lower midday Wednesday after July PCE inflation met monthly forecasts but ran hotter than expected annually, while second-quarter GDP growth was confirmed at an annualized 1.5%.
Novo Nordisk A/S (NYSE: NVO ) stock plunged on Friday after the company announced disappointing headline results from its ZEUS Phase 3 cardiovascular outcomes trial. The data revealed that its experimental drug ziltivekimab failed to reduce the risk of major adverse cardiovascular events compared to placebo in high-ris